Tag Archives: BMS
Judge Throws The Book At Former Bristol-Myers Squibb Exec
Media wordsmiths are competing to outdo one another today in punny reporting on the news that ex-BMS exec Andrew Bodnar has been sentenced to write a book about the role he played in the firm’s 2006 reverse-payments case over generic Plavix.
“Pen-ance: Bristol-Myers Exec Gets Two Years of Hard Writing,†The Wall Street Journal Law Blog [...]
Posted in Legal Also tagged Andrew Bodnar, Bristol Myers Squibb, Federal Bureau of Investigation, Judge Urbina, Park Avenue, Plea, Wall Street Journal, White-collar crime Leave a comment
Icahn to BMS: Offer is Inadequate
In a statement to the press today, ImClone Chairman Carl Icahn said that the review committee overlooking Bristol-Myers Squibb’s offer to purchase the biotech company for $60 per share $4.5 billion just isn’t good enough.
He not only accused BMS of lowballing, but also admitted that the company has been in talks with the head of [...]
Posted in Biotech, Deals, Strategy Also tagged Bristol-Meyers Squibb, Carl Icahn, Deal, Erbitux, ImClone, negotiation, Pharma, sale 1 Comment

New Non-Profit Alliance of Big Pharma Firms